Canada markets closed

NeuroOne Medical Technologies Corporation (NMTC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.8600-0.0300 (-1.59%)
At close: 04:00PM EDT
1.7700 -0.09 (-4.84%)
After hours: 04:46PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 30.64M
Enterprise Value 20.69M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)187.36
Price/Book (mrq)2.89
Enterprise Value/Revenue 137.27
Enterprise Value/EBITDA -1.85

Trading Information

Stock Price History

Beta (5Y Monthly) 0.53
52-Week Change 3-52.67%
S&P500 52-Week Change 3-16.03%
52 Week High 34.2820
52 Week Low 30.5100
50-Day Moving Average 31.6990
200-Day Moving Average 31.5632

Share Statistics

Avg Vol (3 month) 3200.06k
Avg Vol (10 day) 3127.09k
Shares Outstanding 516.21M
Implied Shares Outstanding 6N/A
Float 812.34M
% Held by Insiders 116.88%
% Held by Institutions 121.36%
Shares Short (Aug 30, 2022) 454.29k
Short Ratio (Aug 30, 2022) 40.13
Short % of Float (Aug 30, 2022) 40.35%
Short % of Shares Outstanding (Aug 30, 2022) 40.33%
Shares Short (prior month Jul 28, 2022) 434.22k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:3
Last Split Date 3Mar 31, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Sept 29, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-6,956.89%

Management Effectiveness

Return on Assets (ttm)-65.92%
Return on Equity (ttm)-115.73%

Income Statement

Revenue (ttm)162.06k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)-44.30%
Gross Profit (ttm)-3.72M
EBITDA -11.17M
Net Income Avi to Common (ttm)-11.27M
Diluted EPS (ttm)-0.8250
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)10.18M
Total Cash Per Share (mrq)0.63
Total Debt (mrq)232.01k
Total Debt/Equity (mrq)2.18
Current Ratio (mrq)13.42
Book Value Per Share (mrq)0.66

Cash Flow Statement

Operating Cash Flow (ttm)-10.57M
Levered Free Cash Flow (ttm)-6.58M